Table 2.
Variable | Unadjusted β coefficient | 95%CI | P-value | Adjusted β coefficient | 95%CI | P-value |
---|---|---|---|---|---|---|
cT stage | ||||||
cT1–2 | Ref | Ref | ||||
cT3–4 | 7.76 | 3.64,11.87 | < 0.001 | 6.61 | 2.40,10.81 | 0.002 |
cN stage | ||||||
cN0 | Ref | Ref | ||||
cN+ | 4.12 | 0.29,7.95 | 0.038 | 3.28 | −0.49,7.05 | 0.087 |
Tumor location | ||||||
GEJ | Ref | Ref | ||||
Distal third | 1.41 | −2.99,5.80 | 0.53 | 1.59 | −3.10,6.29 | 0.50 |
Middle third | 6.27 | 1.80,10.75 | 0.007 | 7.01 | 0.71,13.32 | 0.029 |
Superior third | −1.42 | −11.26,8.42 | 0.78 | −1.47 | −12.05,9.11 | 0.78 |
Histology | ||||||
Adenocarcinoma | Ref | |||||
Squamous cell | 3.84 | 0.23,7.45 | 0.040 | −0.630 | −5.84,4.58 | 0.81 |
SUVmax Maximal standardized uptake value, GEJ Gastroesophageal junction, 95%CI 95% confidence intervals, Ref Reference category (β coefficient = 0)